Adalimumab ameliorates memory impairments and neuroinflammation in chronic cerebral hypoperfusion rats

Vascular dementia (VaD) is the second most common type of dementia worldwide. Although there are five FDA-approved drugs for the treatment of Alzheimer’s disease (AD), none of them have been applied to treat VaD. Adalimumab is a TNF-α inhibitor that is used for the treatment of autoimmune diseases s...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Aging (Albany NY)
Hoofdauteurs: Xu, Jing-Jing, Guo, Si, Xue, Rui, Xiao, Lin, Kou, Jun-Na, Liu, Yu-Qiong, Han, Jun-Ya, Fu, Jing-Jie, Wei, Na
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals 2021
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8202885/
https://ncbi.nlm.nih.gov/pubmed/34030135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.203009
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items